Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04760730 · COMPLETED
Trial details
- NCT number
- NCT04760730
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2022-03-29
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.